Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.1 (
chymotrypsin
)
10,938
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Dermal keratin bodies, consisting mainly of keratin intermediate filament aggregates (KIFA) coated with IgM anti-KIF autoantibodies, are present in normal human skin and occur in increased quantities in certain skin diseases. Keratin bodies are normally rapidly removed, but in primary localized cutaneous amyloidosis (PLCA) they are converted by an unknown mechanism to amyloid. Amyloid P component (AP), a glycoprotein identical to, and derived from, the normal plasma protein
serum amyloid P component
(
SAP
), is present in all forms of amyloid including PLCA. We investigated the interaction between
SAP
, keratin bodies, and KIFA. Immunofluorescence staining of normal skin using fluoresceinated anti-
SAP
and rhodamine-conjugated anti-IgM, or AE-1/AE-3 anti-keratin antibodies followed by Texas Red-conjugated anti-mouse immunoglobulin, showed that 52% +/- 4 (mean +/- sem, n = 6) of keratin bodies bound anti-
SAP
. Similar findings were present in a biopsy from a patient with lichen planus. Isolated KIFA, prepared by 8M urea extraction of normal human epidermis or cultured keratinocytes, were preincubated with normal human serum as a source of
SAP
and then stained with fluoresceinated anti-
SAP
. Bright fluorescence seen when the incubation medium contained Ca++ was absent in the presence of ethylenediamine tetraacetic acid. Specific Ca++-dependent binding of
SAP
to KIFA was confirmed using immunoblotting. Binding of
SAP
to KIFA did not prevent their degradation following exposure to trypsin or
alpha-chymotrypsin
. Similarly, partial enzymatic digestion of KIFA did not abrogate their ability to bind
SAP
. Our findings, that
SAP
is associated with keratin bodies in skin and exhibits Ca++-dependent binding to KIFA in vitro, identify keratin filaments as a newly recognized ligand for
SAP
.
...
PMID:Amyloid P component binds to keratin bodies in human skin and to isolated keratin filament aggregates in vitro. 245 1
Human C4b-binding protein (C4BP), which is a regulator of the classical complement pathway C3 convertase, forms high affinity complexes with anticoagulant protein S and with the pentraxin
serum amyloid P component
(
SAP
).
SAP
is a plasma protein present in all amyloid deposits. Recently,
SAP
was shown to inhibit the complement regulatory functions of C4BP. In this investigation, we have studied the structural requirements for the C4BP-
SAP
interaction. C4BP was subjected to
chymotrypsin
digestion, which yielded two major fragments corresponding to the central core (160 kDa) and to the cleaved-off tentacles (48 kDa).
SAP
-Sepharose specifically bound the 160-kDa fragment, suggesting that the central core of C4BP contains the binding site for
SAP
. In a quantitative affinity chromatography assay, the dissociation constants for binding of intact C4BP and of the 160-kDa central core fragment to
SAP
were found to be 30 and 70 nM, respectively. Recombinant C4BP composed of only alpha-chains bound
SAP
with similar affinity (Kd = 22 nM), whereas nonglycosylated recombinant alpha-chain C4BP (synthesized in the presence of tunicamycin) bound
SAP
with lower affinity (Kd = 126 nM). This suggests that the carbohydrate moiety of the central core of C4BP is important for binding of C4BP to
SAP
in contrast to the C4BP beta-chain, which is not required. EDTA, heparin, and phosphorylethanolamine as well as a peptide comprising amino acids 27-39 of
SAP
were found to completely displace C4BP from the
SAP
matrix. Moreover, the immobilized
SAP
peptide bound C4BP in a reaction that, in contrast to the C4BP-
SAP
interaction, was not dependent on calcium.
...
PMID:Serum amyloid P component binding to C4b-binding protein. 759 41
A heparin-binding peptide fragment from
chymotrypsin
-treated human
serum amyloid P component
(
SAP
) was demonstrated by affinity CE. The peptide was found in a fraction of peptides that were not separated well by reversed-phase HPLC. On the basis of mass determination by laser desorption mass spectrometry after preparative CE, the fragment could be placed in the parent protein structure. Thus, in the course of the study of structure-function relationships of
SAP
, CE was helpful for the examination of peptide fragments from proteolytic digests that were poorly separated by standard reversed-phase HPLC methods and for the purification of peptides in the mixture.
...
PMID:Preparative capillary electrophoresis and mass spectrometry for the identification of a putative heparin-binding site in amyloid P component. 938 79